You searched for prescription-drugs | Page 75 of 180

A Look at People Who Have Persistently High Spending on Health Care

Jul 23, 2019

Issue Brief

This analysis looks at the amounts and types of health spending for people with employer-based health insurance who have continuing high health care spending. It finds that, among people with three consecutive years of coverage from a large employer, just 1.3 percent of enrollees accounted for almost 20 percent of overall spending in 2017. This group – people in the top five percent of spending in each of the three years from 2015 to 2017…

10 Things to Know About Medicare Part D Coverage and Costs in 2019

Jun 4, 2019

Issue Brief

The Medicare Part D program provides an outpatient prescription drug benefit to older adults and people with long-term disabilities in Medicare who enroll in private plans. This analysis provides the latest data about Medicare Part D coverage and costs in 2019 and trends over time, including enrollment, premiums, cost sharing, and participation in the low-income subsidy program.

What Initiatives Are States Considering To Control Prescription Drug Costs in Medicaid?

Feb 21, 2018

News Release

Rising Medicaid spending on prescription drugs has prompted many states to look for new ways to control such costs. Although drug spending increased more slowly in 2016 than in the previous two years, and although such expenditures constitute only six percent of all Medicaid spending (compared to 10% of national health spending), the high cost of specialty drugs continues to be a particular concern among Medicaid policy directors. A new issue brief from the Kaiser…

Snapshots of Recent State Initiatives in Medicaid Prescription Drug Cost Control

Feb 21, 2018

Issue Brief

This issue brief provides a snapshot of current state initiatives aimed at addressing the cost of prescription drugs in Medicaid.

Kaiser Health Tracking Poll – March 2018: Views on Prescription Drug Pricing and Medicare-for-all Proposals

Mar 23, 2018

Feature

More than a year into President Trump’s presidency, the March Kaiser Health Tracking Poll gauges the public’s top priorities for the president and Congress to do in the coming months. This month’s poll also measures perceptions on the cost of prescription drugs, attitudes towards policymakers’ actions to address drug prices, and views of pharmaceutical companies. In addition, with the 2018 midterm elections less than 8 months away, the KFF poll asks how important a national…

Medicaid and CHIP Eligibility, Enrollment, and Cost Sharing Policies as of January 2020: Findings from a 50-State Survey

Mar 26, 2020

Report

This 18th annual survey of the 50 states and the District of Columbia (DC) provides data on Medicaid and the Children’s Health Insurance Program (CHIP) eligibility, enrollment, renewal, and cost sharing policies as of January 2020. The survey findings highlight state variation in policies that affect individuals’ ability to access coverage and care amid the COVID-19 public health crisis. They also provide examples of actions states can take to expand eligibility and simplify enrollment to…

Kaiser Health News (KHN) Wins Prestigious Barlett & Steele Investigative Journalism Award

Oct 2, 2019

News Release

KFF is pleased to announce that Kaiser Health News (KHN), its editorially independent health news service, won a top prize in the 13th annual Barlett & Steele Awards for Investigative Journalism.

Summary of Recent and Proposed Changes to Medicare Prescription Drug Coverage and Reimbursement

Feb 15, 2018

Issue Brief

On February 9, 2018 the President signed into law the Bipartisan Budget Act of 2018, which included some provisions related to Medicare Part D prescription drug coverage. Shortly thereafter, the Office of Management and Budget released the President’s fiscal year (FY) 2019 budget, which also included several proposals related to Medicare Part D drug coverage and Part B drug reimbursement. This brief summarizes these recently enacted and proposed changes.

Among the Most Commonly Used Antiretrovirals Covered by Part D in 2017, 9 of 10 Had List Prices Exceeding Inflation

Dec 18, 2019

Feature

9 of 10 Most Commonly Used ARVs in Part D Had List Prices Above Inflation Download

Among the 10 Antiretrovirals with the Highest Part D Spending in 2017, All Had List Price Increases Exceeding Inflation

Dec 18, 2019

Feature

All 10 Part D ARVs w Highest Spending Had Price Increases Above Inflation Download

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter